Open access · CC-BY
via OpenAlex
Aging and Mesenchymal Stem Cells: Basic Concepts, Challenges and Strategies
María Fraile, Noemí Eiró, Luis A. Costa, Arancha Martín, Francisco José Vizoso
Biology · 2022 · ▲ 72 citations
Mitochondrial dysfunction
Cellular senescence
Stem-cell exhaustion
Altered intercellular communication
Chronic inflammation
Disabled macroautophagy
Senolytics
Stem-cell therapy
Review
Abstract
Aging and frailty are complex processes implicating multifactorial mechanisms, such as replicative senescence(definition), oxidative stress, mitochondrial dysfunction(definition), or autophagy(definition) disorder. All of these mechanisms drive dramatic changes in the tissue environment, such as senescence-associated secretory phenotype factors and inflamm-aging. Thus, there is a demand for new therapeutic strategies against the devastating effects of the aging and associated diseases. Mesenchymal stem cells (MSC) participate in a "galaxy" of tissue signals (proliferative, anti-inflammatory, and antioxidative stress, and proangiogenic, antitumor, antifibrotic, and antimicrobial effects) contributing to tissue homeostasis. However, MSC are also not immune to aging. Three strategies based on MSC have been proposed: remove, rejuvenate, or replace the senescent MSC. These strategies include the use of senolytic drugs, antioxidant agents and genetic engineering, or transplantation of younger MSC. Nevertheless, these strategies may have the drawback of the adverse effects of prolonged use of the different drugs used or, where appropriate, those of cell therapy. In this review, we propose the new strategy of "Exogenous Restitution of Intercellular Signalling of Stem Cells" (ERISSC). This concept is based on the potential use of secretome from MSC, which are composed of molecules such as growth factors, cytokines, and extracellular vesicles and have the same biological effects as their parent cells. To face this cell-free regenerative therapy challenge, we have to clarify key strategy aspects, such as establishing tools that allow us a more precise diagnosis of aging frailty in order to identify the therapeutic requirements adapted to each case, identify the ideal type of MSC in the context of the functional heterogeneity of these cellular populations, to optimize the mass production and standardization of the primary materials (cells) and their secretome-derived products, to establish the appropriate methods to validate the anti-aging effects and to determine the most appropriate route of administration for each case.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/biology11111678
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Fraile, M., Eiró, N., Costa, L.A., Martín, A., & Vizoso, F.J. (2022). Aging and Mesenchymal Stem Cells: Basic Concepts, Challenges and Strategies. <em>Biology</em>. https://doi.org/10.3390/biology11111678
Vancouver
Fraile M, Eiró N, Costa LA, Martín A, Vizoso FJ. Aging and Mesenchymal Stem Cells: Basic Concepts, Challenges and Strategies. Biology. 2022. doi:10.3390/biology11111678.
BibTeX
@article{mara2022Aginga,
title = {Aging and Mesenchymal Stem Cells: Basic Concepts, Challenges and Strategies},
author = {María Fraile and Noemí Eiró and Luis A. Costa and Arancha Martín and Francisco José Vizoso},
journal = {Biology},
year = {2022},
doi = {10.3390/biology11111678},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Accounts of Chemical Research 2024
Open access · CC-BY
Chemical Strategies for the Detection and Elimination of Senescent Cells
International Journal of Molecular Sciences 2021
Open access · CC-BY
Mesenchymal Stem Cells as a Cornerstone in a Galaxy of Intercellular Signals: Basis for a New Era of Medicine
Stem Cells Translational Medicine 2022
Open access · CC-BY
Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies
npj Aging 2026
Open access · CC-BY
Emerging strategies in senotherapeutics: from broad-spectrum senolysis to precision reprogramming
npj aging 2026
Open access · OA
Emerging strategies in senotherapeutics: from broad-spectrum senolysis to precision reprogramming.
Gerontology 2016
Open access · CC-BY